{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:22:10Z","timestamp":1778070130426,"version":"3.51.4"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"2024 Annual Funding for Science and Technology Research Projects of the Jiangxi Provincial Department of Education","award":["GJJ2402518"],"award-info":[{"award-number":["GJJ2402518"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"abstract":"<jats:p>\n                    This study aimed to evaluate the efficacy and safety of low-concentration atropine combined with spectacles in controlling myopia progression among school-aged children and to assess treatment differences across age and refractive subgroups. This retrospective controlled study included 80 myopic children (160 eyes) who visited our center between January 2022 and January 2024. Among them, 40 patients (80 eyes) received low-concentration atropine combined with spectacles (combination group), and 40 patients (80 eyes) used spectacles alone (control group). All participants completed baseline, 6-, 12-, and 18-month follow-ups. Changes in spherical equivalent (SE), axial length, visual function (including best-corrected visual acuity and amplitude of accommodation) and adverse events were compared between groups. Subgroup analyses were conducted according to age and baseline refractive error. Statistical analyses included\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    tests, chi-square tests, and repeated-measures analysis of variance. Baseline demographic and refractive parameters did not differ significantly between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). After 18 months, myopia progression was significantly slower in the combination group compared with the control group (\u20130.45\u2005\u00b1\u20050.33 D vs \u20131.00\u2005\u00b1\u20050.39 D,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), with an annual progression rate of approximately \u20130.30 D\/year. Axial elongation was also significantly reduced (0.19\u2005\u00b1\u20050.14\u2009mm vs 0.36\u2005\u00b1\u20050.17\u2009mm,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and SE change was positively correlated with axial growth (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    \u2005=\u20050.70,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Best-corrected visual acuity remained stable in both groups, while amplitude of accommodation increased significantly in the combination group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.03). Mild and reversible adverse reactions occurred in 10.0% of the combination group, primarily transient photophobia and near blur, with no serious events reported. Subgroup analysis revealed greater efficacy in younger children aged 6 to 8 years and those with baseline SE\u2005\u2264\u2005\u20132.00 D (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Low-concentration atropine combined with spectacles effectively slows myopia progression and axial elongation in children aged 6 to 10 years while maintaining stable visual function and demonstrating good safety and tolerability. The combined intervention provides superior control compared to optical correction alone, particularly benefiting younger and early-onset myopic children. These findings offer new clinical evidence supporting the combined application of low-concentration atropine in pediatric myopia management.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047770","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:01:04Z","timestamp":1773432064000},"page":"e47770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective comparison of myopia progression between low-concentration atropine combined with spectacles and spectacles alone in myopic children aged 6 to 10 years"],"prefix":"10.1097","volume":"105","author":[{"given":"Zhen","family":"Ning","sequence":"first","affiliation":[{"name":"Nanchang Key Laboratory of Glycolipid Metabolism and Chronic Diseases, Jiangxi institute of Technology, Nanchang City, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Rong","sequence":"additional","affiliation":[{"name":"Nanchang Key Laboratory of Glycolipid Metabolism and Chronic Diseases, Jiangxi institute of Technology, Nanchang City, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Ding","sequence":"additional","affiliation":[{"name":"Nanchang Key Laboratory of Glycolipid Metabolism and Chronic Diseases, Jiangxi institute of Technology, Nanchang City, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqing","family":"Xiang","sequence":"additional","affiliation":[{"name":"Nanchang Key Laboratory of Glycolipid Metabolism and Chronic Diseases, Jiangxi institute of Technology, Nanchang City, Jiangxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2366-857X","authenticated-orcid":false,"given":"Liqiang","family":"Ge","sequence":"additional","affiliation":[{"name":"General Internal Medicine Department, Jiangxi Provincial Children\u2019s Hospital, Nanchang City, Jiangxi Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s40123-025-01243-7","article-title":"Intraocular pressure trends in children with myopia receiving atropine therapy.","volume":"14","author":"Hsia","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"100688","DOI":"10.1016\/j.xops.2024.100688","article-title":"Changes in choroidal thickness of healthy children during myopia progression over 4 years: boramae myopia cohort study report 5.","volume":"5","author":"Lee","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"1571470","DOI":"10.3389\/fmed.2025.1571470","article-title":"Comparison of spherical equivalent and estimated prevalence of myopia in school-age children between Shanghai and Yunnan in China.","volume":"12","author":"Li","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.4103\/jfmpc.jfmpc_1339_22","article-title":"Efficacy of atropine for myopia control in children: a meta-analysis of randomized controlled trials.","volume":"11","author":"Kumari","year":"2022","journal-title":"J Family Med Primary Care"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/opo.12929","article-title":"Dietary intake and associations with myopia in Singapore children.","volume":"42","author":"Li","year":"2021","journal-title":"Ophthal Physl Opt"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/08164622.2023.2216840","article-title":"Effects of online family health education on myopia prevention in children by parental myopia: a randomized clinical trial.","volume":"107","author":"Zhang","year":"2023","journal-title":"Clin Exp Optom"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00417-023-06338-0","article-title":"Association between sleep and myopia in children and adolescents: a systematic review and meta-analysis.","volume":"262","author":"Jin","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-20260506","first-page":"442","article-title":"Epidemiological characteristics of myopia and pre-myopia among preschool children aged 5\u20136 years in ten provinces of China.","volume":"57","author":"Tang","year":"2025","journal-title":"Beijing Da Xue Xue Bao"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"1563305","DOI":"10.3389\/fpubh.2025.1563305","article-title":"Prediction of myopia based on biometric parameters of 500,000 children and adolescents aged 3\u201318 years.","volume":"13","author":"Chen","year":"2025","journal-title":"Front Public Health"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/opo.13563","article-title":"Factors predicting myopia incidence in China and Europe.","volume":"45","author":"Tahhan","year":"2025","journal-title":"Ophthalmic Physiol Opt"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"18","DOI":"10.17116\/oftalma202414005118","article-title":"Early changes in choroidal thickness and axial length in the use glasses of monofocal lenses and highly aspherical lenslets in children with newly diagnosed myopia.","volume":"140","author":"Tarutta","year":"2024","journal-title":"Vestn Oftalmol"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"29","DOI":"10.17116\/oftalma202514104129","article-title":"Clinical experience with 0.01% atropine for myopia control in children in Azerbaijan.","volume":"141","author":"Galbinur","year":"2025","journal-title":"Vestn Oftalmol"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/joco.joco_344_22","article-title":"Myopia controlling using low dose atropine eye drop.","volume":"36","author":"Rajavi","year":"2024","journal-title":"J Curr Ophthalmol"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ceo.14368","article-title":"Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia \u2013 Atropine for the Treatment of Myopia (WA-ATOM) study.","volume":"52","author":"Lee","year":"2024","journal-title":"Clin Exp Ophthalmol"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.18240\/ijo.2024.11.20","article-title":"Retardation of myopia by atropine regimes.","volume":"17","author":"Zhu","year":"2024","journal-title":"Int J Ophthalmol"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"e18743","DOI":"10.1016\/j.heliyon.2023.e18743","article-title":"Effects of atropine 0.01% on refractive errors in children with myopia.","volume":"9","author":"Zhu","year":"2023","journal-title":"Heliyon"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10384-025-01212-4","article-title":"Evaluating efficacy of 0.125% atropine using a myopia progression machine learning model.","volume":"69","author":"Han","year":"2025","journal-title":"Jpn J Ophthalmol"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/OPX.0000000000002028","article-title":"A survey of myopia correction pattern of children and parent\u2019s attitudes in China.","volume":"100","author":"Yang","year":"2023","journal-title":"Optometr Vision Sci"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1364\/BOE.486555","article-title":"Comparison of optical myopia control interventions: effect on peripheral image quality and vision.","volume":"14","author":"Papadogiannis","year":"2023","journal-title":"Biomed Opt Express"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"100578","DOI":"10.1016\/j.optom.2025.100578","article-title":"Effects of weekly unilateral application of 1% atropine on reducing anisometropia in Chinese children with low myopia.","volume":"18","author":"Lu","year":"2025","journal-title":"J Optom"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/opo.70018","article-title":"0.01% Atropine for Myopia Prevention in Pre-myopia (AMPP study).","volume":"45","author":"He","year":"2025","journal-title":"Ophthalmic Physiol Opt"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"1161329","DOI":"10.3389\/fped.2023.1161329","article-title":"Myopia among children and adolescents: an epidemiological study in Fuzhou City.","volume":"11","author":"Zhu","year":"2023","journal-title":"Front Pediatr"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12886-023-03175-x","article-title":"Orthokeratology in controlling myopia of children: a meta-analysis of randomized controlled trials.","volume":"23","author":"Li","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.apjo.2024.100122","article-title":"Low-concentration atropine for controlling myopia onset and progression in East Asia.","volume":"13","author":"Zaabaar","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R26-20260506","doi-asserted-by":"crossref","first-page":"1503536","DOI":"10.3389\/fphar.2024.1503536","article-title":"Effectiveness of various atropine concentrations in myopia control for Asian children: a network meta-analysis.","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"R27-20260506","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00431-023-04921-5","article-title":"Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children \u2013 a prospective, randomized, double-masked, and crossover trial.","volume":"182","author":"Wang","year":"2023","journal-title":"Eur J Pediatr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:06:56Z","timestamp":1778069216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047770","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}